Cargando…

Does ACPA-negative RA consist of subgroups related to sustained DMARD-free remission and serological markers at disease presentation? Comment on article by Boeters DM et al.

Detalles Bibliográficos
Autores principales: Masi, Alfonse T., Fleischmann, Roy
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6993512/
https://www.ncbi.nlm.nih.gov/pubmed/32005276
http://dx.doi.org/10.1186/s13075-020-2106-5
_version_ 1783493051436498944
author Masi, Alfonse T.
Fleischmann, Roy
author_facet Masi, Alfonse T.
Fleischmann, Roy
author_sort Masi, Alfonse T.
collection PubMed
description
format Online
Article
Text
id pubmed-6993512
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-69935122020-02-04 Does ACPA-negative RA consist of subgroups related to sustained DMARD-free remission and serological markers at disease presentation? Comment on article by Boeters DM et al. Masi, Alfonse T. Fleischmann, Roy Arthritis Res Ther Letter BioMed Central 2020-01-31 2020 /pmc/articles/PMC6993512/ /pubmed/32005276 http://dx.doi.org/10.1186/s13075-020-2106-5 Text en © The Author(s). 2020 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Letter
Masi, Alfonse T.
Fleischmann, Roy
Does ACPA-negative RA consist of subgroups related to sustained DMARD-free remission and serological markers at disease presentation? Comment on article by Boeters DM et al.
title Does ACPA-negative RA consist of subgroups related to sustained DMARD-free remission and serological markers at disease presentation? Comment on article by Boeters DM et al.
title_full Does ACPA-negative RA consist of subgroups related to sustained DMARD-free remission and serological markers at disease presentation? Comment on article by Boeters DM et al.
title_fullStr Does ACPA-negative RA consist of subgroups related to sustained DMARD-free remission and serological markers at disease presentation? Comment on article by Boeters DM et al.
title_full_unstemmed Does ACPA-negative RA consist of subgroups related to sustained DMARD-free remission and serological markers at disease presentation? Comment on article by Boeters DM et al.
title_short Does ACPA-negative RA consist of subgroups related to sustained DMARD-free remission and serological markers at disease presentation? Comment on article by Boeters DM et al.
title_sort does acpa-negative ra consist of subgroups related to sustained dmard-free remission and serological markers at disease presentation? comment on article by boeters dm et al.
topic Letter
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6993512/
https://www.ncbi.nlm.nih.gov/pubmed/32005276
http://dx.doi.org/10.1186/s13075-020-2106-5
work_keys_str_mv AT masialfonset doesacpanegativeraconsistofsubgroupsrelatedtosustaineddmardfreeremissionandserologicalmarkersatdiseasepresentationcommentonarticlebyboetersdmetal
AT fleischmannroy doesacpanegativeraconsistofsubgroupsrelatedtosustaineddmardfreeremissionandserologicalmarkersatdiseasepresentationcommentonarticlebyboetersdmetal